Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

NCT04270175 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Amyloid
AL Amyloidosis
Refractory AL Amyloidosis

Interventions

DRUG: Daratumumab SC
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]